lactic acid has been researched along with lenvatinib in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al Qtaish, N; Caruana, P; Céspedes, MV; Corcoy, R; Edwards, M; Escolà-Gil, JC; Gallego, I; Li, C; Lopez-Mendez, T; Mato, E; Moral, A; Paez-Espinosa, V; Pedraz, JL; Pérez, JI; Puras, G; Revilla, G; Rodriguez, F; Sainz-Ramos, M; Vallverdú, NF | 1 |
1 other study(ies) available for lactic acid and lenvatinib
| Article | Year |
|---|---|
Lenvatinib-Loaded Poly(lactic-co-glycolic acid) Nanoparticles with Epidermal Growth Factor Receptor Antibody Conjugation as a Preclinical Approach to Therapeutically Improve Thyroid Cancer with Aggressive Behavior.
Topics: Animals; Cell Line, Tumor; Cetuximab; Drug Carriers; ErbB Receptors; Glycols; Humans; Iodine Radioisotopes; Lactic Acid; Mice; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Quality of Life; Thyroid Neoplasms; Tissue Distribution | 2023 |